|
|
|
|
|
|
|
15.12.25 - 14:21
|
Cross Country Healthcare Announces CEO Transition (Business Wire)
|
|
|
Co-Founder and Chairman, Kevin C. Clark, Returns as Chief Executive Officer
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company” and “Cross Country”) (Nasdaq: CCRN) today announced that John A. Martins, the Company's President and Chief Executive Officer, has separated from the Company and ceased to serve as a member of its Board of Directors (the “Board”), effective as of December 14, 2025. The Board appointed Kevin C. Clark, the Company's current Chairman, former Chief Executive Officer, and Co-Founder, to succeed Mr. Martins as the Company's President and Chief Executive Officer. Mr. Clark will continue to serve as the Chairman of the Board.
“The Board members are thrilled to have Kevin return as Cross Country's CEO to embark on a new chapter of growth,” said Cross Country's Lead Independent Director, Larry Cash. “Kevin brings nearly 40 years of experience in the healthcare staffing industry. He co-founded Cross Country in 1986, serving as Chairman and...
|
|
|
|
|
|
|
|
|
|
|
|
|
12.11.25 - 23:00
|
Cross Country Healthcare Announces Third Quarter 2025 Financial Results (Business Wire)
|
|
|
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2025.
Selected Financial Information:
Variance
Variance
Q3 2025 vs
Q3 2025 vs
Dollars are in thousands, except per share amounts
Q3 2025
Q3 2024
Q2 2025
Revenue
$
250,052
(21
)%
(9
)%
Gross profit margin*
20.4
%
—
bps
—
bps
Net loss attributable to common stockholders
$
(4,774
)
(287
)%
28
%
Diluted EPS
$
(0.15
)
$
(0.23
)
$
0.05
Adjusted EBITDA*
$
6,524
(37
)%
(14
)%
Adjusted EBITDA margin*
2.6
%
(70
)bps
(20
)bps
Adjusted EPS*
$
0.03
$
(0.09
)
$
0.04
Cash flows provided by operations
$
20,114
169
%
377
%
* Represents amounts that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP) and are referred to as non-GAAP measures. Please refer to the accompanying discussion below of how these non-GAAP financial measures are calc...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07.05.25 - 22:18
|
Cross Country Healthcare Announces First Quarter 2025 Financial Results (Business Wire)
|
|
|
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2025.
SELECTED FINANCIAL INFORMATION:
Variance
Variance
Q1 2025 vs
Q1 2025 vs
Dollars are in thousands, except per share amounts
Q1 2025
Q1 2024
Q4 2024
Revenue
$
293,408
(23
)
%
(5
)
%
Gross profit margin*
20.0
%
(40
)
bps
—
bps
Net loss attributable to common stockholders
$
(490
)
(118
)
%
87
%
Diluted EPS
$
(0.02
)
$
(0.10
)
$
0.10
Adjusted EBITDA*
$
8,619
(44
)
%
(7
)
%
Adjusted EBITDA margin*
2.9
%
(110
)
bps
(10
)
bps
Adjusted EPS*
$
0.06
$
(0.13
)
$
0.02
Cash flows provided by operations
$
5,681
(5
)
%
(77
)
%
* Represents amounts that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP) and are referred to as non-GAAP measures. Please refer to the accompanying discussion b...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
